Article Information
History
- August 4, 2016.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Amy Guillaumet-Adkins1,26,
- Gustavo Rodríguez-Esteban1,26,
- Elisabetta Mereu1,2,
- Alberto Villanueva3,4,
- August Vidal5,
- Marta Gut1,2,
- Ivo Gut1,2 and
- Holger Heyn1,2,*
- 1Centro Nacional de Análisis Genómico (CNAG-CRG) - Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
- 2Universitat Pompeu Fabra (UPF), Barcelona, Spain
- 3Chemoresistance and Predictive Factors Laboratory, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain
- 4Xenopat S.L., Business Bioincubator, Bellvitge Health Science Campus, Barcelona, Spain
- 5Department of Pathology, University Hospital of Bellvitge (IDIBELL), Barcelona, Spain
- ↵*Correspondence: holger.heyn@cnag.crg.eu
↵6 Authors contributed equally